About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2/3NCT00662831

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients

The purpose of the study isto see the effect of Fragmin on the healing of diabetic foot ulcers by determining the number of subjects with ≥50% reduction in ulcer surface area including intact skin hea...

Lead sponsor: Pfizer•63 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Pfizer

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male or female subjects 18 years of age with type 1 or type 2 diabetes.
•Subjects with peripheral occlusive arterial disease (PAOD) and a neuropathy disability score (NDS) of \>3

Exclusion Criteria

•Subjects who have undergone vascular reconstruction or angioplasty less than 1 month prior to randomization. Subjects with an ulcer grading of 0 or 3 and staging of A, B or D according to the University of Texas wound classification system.
•Subjects with a known bleeding disorder or evidence of active bleeding.

Related studies

RECRUITINGPhase 2

BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers

NCT06383013 · Diabetic Foot Ulcer

PAW-Hydrogel for Chronic Wound Healing

NCT07541196 · Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU), and more

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers

NCT07039396 · Diabetic Foot Ulcer

Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs

NCT06449638 · Diabetic Foot Ulcer (DFU), Ulcer Foot, and more

RECRUITINGPhase 1/2

Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

NCT07396376 · Diabetic Foot Ulcer, Wagner Grade 1 - 2, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 19, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2/PHASE3

Enrollment276

Start dateApr 2008

Last updatedDec 19, 2018

Condition

Diabetic Foot Ulcer

Locations shown

Pfizer Investigational Site

Klagenfurt

Pfizer Investigational Site

Vienna

Pfizer Investigational Site

Vienna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 19, 2018Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions